Form 4: Stoke Therapeutics Executive Jonathan Allan Reports Stock Transactions

Jonathan Allan, General Counsel & Corp Sec of Stoke Therapeutics, reports acquisition and disposal of common stock and restricted stock units.

Summary

• On March 15, 2024, Jonathan Allan, General Counsel & Corp Sec of Stoke Therapeutics, acquired 7,475 shares of common stock at $0 and disposed of 7,475 restricted stock units.
• Following these transactions, Allan directly owns 10,073 shares of common stock.
• On March 19, 2024, Allan sold 2,349 shares at a weighted average price of $6.0986, resulting in direct ownership of 7,724 shares.
• The sale was mandated by the Issuer to satisfy tax withholding liabilities related to the vesting of restricted stock units.
• Allan also owns 22,425 restricted stock units, which vest annually beginning March 15, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are routine and related to compensation and tax obligations.

Positives

• The vesting of restricted stock units indicates a form of compensation and alignment of interests between the executive and the company's performance.

Negatives

• The sale of shares to cover tax liabilities could be perceived negatively, although it is a common practice.

Risks

• Executive stock sales can sometimes be interpreted negatively by the market, although in this case, it is primarily for tax obligations.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value.
• Sales of shares to cover tax liabilities upon vesting are a common practice among executives in publicly traded companies.

Stakeholder Impact

• The transactions have a limited direct impact on stakeholders, as they primarily reflect executive compensation and tax management.

Key Dates